Archive for the ‘Blood / Hematology’ Category

CaridianBCT And American Red Cross Sign Strategic Agreement On Automated Blood Collection Technology

Wednesday, October 8th, 2008
CaridianBCT, a leading global provider of technology, products and services in automated blood collections, therapeutic systems, whole blood processes and pathogen reduction technologies, announced today it has signed a multi-year agreement with the American Red Cross to continue the use of its automated blood collection technology in American Red Cross Blood centers throughout the United States.

Belt And Braces Approach May Prevent Deep Vein Thromboses

Wednesday, October 8th, 2008
Combining short periods of leg compression with medications such as heparin is more effective at preventing blood clots in high-risk patients than using either preventative measure alone. A team of Cochrane Researchers believe that this 'belt and braces' approach can significantly decrease a patient's risk of deep vein thrombosis (DVT).

Israeli Device Could Replace Anticoagulants In Surgery - Non-invasive Mobile Compression System That Helps Keep The Blood Circulating In The Limbs

Monday, October 6th, 2008
Surgeons are always concerned about the hazard of deep vein thrombosis (DVT) in their patients. In the wake of surgery, blood clots can form deep in the body, leading to pain and swelling, or - if the clot starts to move - even death.

CaridianBCT Initiates Clinical Trial For Whole Blood Process With Mirasol® Pathogen Reduction Technology

Monday, October 6th, 2008
CaridianBCT, a leading global provider of technology, products and services in automated blood collections, therapeutic systems, whole blood processes and pathogen reduction technologies, announced today that it has initiated a clinical trial for treating whole blood with Mirasol Pathogen Reduction Technology (PRT) after receiving clearance from the U.S. Food and Drug Administration (FDA) and U.S.

GSK Update On FDA Review Of Promacta® (eltrombopag)

Saturday, October 4th, 2008
GlaxoSmithKline announced that the United States Food and Drug Administration (FDA)continues to review the new drug application for Promacta® (eltrombopag) beyond the September 19, 2008 action date.

Bayer’s Novel Oral Anticoagulant Xarelto(R) (Rivaroxaban) Gets European Licence

Friday, October 3rd, 2008
Today the UK's 160,000 elective hip and knee replacement patients1 will be eligible to receive Bayer Schering Pharma's new oral anticoagulant, rivaroxaban. This follows European Commission authorisation of its licence for the prevention of venous thromboembolism (deep vein thrombosis (DVT) and pulmonary embolism (PE)), in patients undergoing elective hip or knee replacement surgery.

Pradaxa - First New Oral Medication To Stop Blood Clotting In Over 50 Years Launched In Ireland Today

Thursday, October 2nd, 2008
The first new oral medication to stop blood  clotting  since  the  launch of warfarin in the early 1950s has been launched  today.   Pradaxa*  (dabigatran  etexilate)  is the first of a new class  of  oral  anticoagulants  - a direct thrombin inhibitor - to be made available  in  Ireland  by  Boehringer Ingelheim.

CLSI Publishes Updated Standard For Collection Of Diagnostic Capillary Blood Specimens

Thursday, October 2nd, 2008
Clinical and Laboratory Standards Institute (CLSI) recently published an updated standard, Procedures and Devices for the Collection of Diagnostic Capillary Blood Specimens; Approved Standard--Sixth Edition (H04-A6), which provides a technique for the collection of diagnostic capillar

Chinese Officials Announce Stricter Punishment For Contaminated Blood Sales

Thursday, September 25th, 2008
The Supreme People's Court and the Supreme People's Procuratorate of China recently released details of a new law regarding illegal blood sales, which state that any agent collecting or supplying blood that causes at least five people to become infected with HIV/AIDS, hepatitis B, hepatitis C or sy

Joint Commission Alert: Prevent Blood Thinner Deaths And Overdoses - Anticoagulant Therapy Linked To High Rate Of Errors

Thursday, September 25th, 2008
A number of recent high profile errors related to commonly used blood thinners highlight a safety issue that too frequently results in harm or even death to patients, according to a Joint Commission alert issued today that offers solutions to this medication safety issue.